Washington – As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy. Prescriptions for ketamine have soared in recent years, driven by for-profit clinics and telehealth services offering the…Read More
Related Posts
Lipocine Announces Financial Results for the First Quarter Ended March 31 2023
SALT LAKE CITY, May 11, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its proprietary platform to develop…
Oncology researchers raise ethics concerns posed by patientfacing AI News Room Odisha
New York: Patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies to schedule appointments, monitor their health, learn about their disease and its treatment, find…
Oracle brings generative AI capabilities to healthcare unveils new capabilities Weekly Voice
Las Vegas, Sep 19 (VOICE) Cloud major Oracle has announced new capabilities that combine the power of generative AI and voice to help providers focus more on patient engagement, building…
